124 related articles for article (PubMed ID: 9095355)
1. Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Barrett JA; Crocker AC; Damphousse DJ; Heminway SJ; Liu S; Edwards DS; Lazewatsky JL; Kagan M; Mazaika TJ; Carroll TR
Bioconjug Chem; 1997; 8(2):155-60. PubMed ID: 9095355
[TBL] [Abstract][Full Text] [Related]
2. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugates.
Barrett JA; Damphousse DJ; Heminway SJ; Liu S; Edwards DS; Looby RJ; Carroll TR
Bioconjug Chem; 1996; 7(2):203-8. PubMed ID: 8983342
[TBL] [Abstract][Full Text] [Related]
4. A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands.
Liu S; Edwards DS; Harris AR
Bioconjug Chem; 1998; 9(5):583-95. PubMed ID: 9736492
[TBL] [Abstract][Full Text] [Related]
5. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.
Liu S; Edwards DS; Looby RJ; Harris AR; Poirier MJ; Barrett JA; Heminway SJ; Carroll TR
Bioconjug Chem; 1996; 7(1):63-71. PubMed ID: 8741992
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide.
Lister-James J; Vallabhajosula S; Moyer BR; Pearson DA; McBride BJ; De Rosch MA; Bush LR; Machac J; Dean RT
J Nucl Med; 1997 Jan; 38(1):105-11. PubMed ID: 8998163
[TBL] [Abstract][Full Text] [Related]
7. Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.
Mousa SA; Bozarth JM; Edwards S; Carroll T; Barrett J
Coron Artery Dis; 1998; 9(2-3):131-41. PubMed ID: 9647415
[TBL] [Abstract][Full Text] [Related]
8. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide.
Lister-James J; Knight LC; Maurer AH; Bush LR; Moyer BR; Dean RT
J Nucl Med; 1996 May; 37(5):775-81. PubMed ID: 8965144
[TBL] [Abstract][Full Text] [Related]
9. Imaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venom.
Knight LC; Baidoo KE; Romano JE; Gabriel JL; Maurer AH
J Nucl Med; 2000 Jun; 41(6):1056-64. PubMed ID: 10855635
[TBL] [Abstract][Full Text] [Related]
10. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
Pearson DA; Lister-James ; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Dean RT
J Med Chem; 1996 Mar; 39(7):1372-82. PubMed ID: 8691467
[TBL] [Abstract][Full Text] [Related]
11. Technetium Complexes of a Hydrazinonicotinamide-Conjugated Cyclic Peptide and 2-Hydrazinopyridine: Synthesis and Characterization.
Liu S; Edwards DS; Harris AR; Heminway SJ; Barrett JA
Inorg Chem; 1999 Mar; 38(6):1326-1335. PubMed ID: 11670921
[TBL] [Abstract][Full Text] [Related]
12. Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model.
Knight LC; Maurer AH; Romano JE
J Nucl Med; 1996 Mar; 37(3):476-82. PubMed ID: 8772651
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclic peptide.
Edwards DS; Liu S; Harris AR; Poirier MJ; Ewels BA
Bioconjug Chem; 1999; 10(5):803-7. PubMed ID: 10502346
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
Rübsamen K; Hornberger W; Kirchengast M
Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122
[TBL] [Abstract][Full Text] [Related]
15. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
Goto S; Tamura N; Ishida H; Ruggeri ZM
J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
[TBL] [Abstract][Full Text] [Related]
16. Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets.
Knight LC; Radcliffe R; Maurer AH; Rodwell JD; Alvarez VL
J Nucl Med; 1994 Feb; 35(2):282-8. PubMed ID: 8295000
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.
Fang W; He J; Kim YS; Zhou Y; Liu S
Bioconjug Chem; 2011 Aug; 22(8):1715-22. PubMed ID: 21780818
[TBL] [Abstract][Full Text] [Related]
18. Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report.
Klem JA; Schaffer JV; Crane PD; Barrett JA; Henry GA; Canestri L; Ezekowitz MD
J Nucl Cardiol; 2000; 7(4):359-64. PubMed ID: 10958278
[TBL] [Abstract][Full Text] [Related]
19. In vitro platelet binding compared with in vivo thrombus imaging using alpha(IIb)beta3-targeted radioligands.
Knight LC; Romano JE; Maurer AH
Thromb Haemost; 1998 Nov; 80(5):845-51. PubMed ID: 9843182
[TBL] [Abstract][Full Text] [Related]
20. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
